EUVIMEDΑνακαλύψτε το EUVIMED
Video/Audio

Adjunctive Trazodone Effects on Sleep, Mood, and Circulating 5-HT and BDNF in Depression

Juyan Li, Lingling Li, Qiuying Li, Suoyuan Zhang, Yun Bian

Journal of Visualized Experiments · 2026-10-30 · (236)

DOI: 10.3791/73296 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, published online on 2026-10-30. Written by Juyan Li and 4 co-authors. Institution: Department of Psychosomatic Medicine, Ward 13, Beijing Hui Long Guan Hospital, Capital Medical University. Major MEDLINE topics: Trazodone, Brain-Derived Neurotrophic Factor, Serotonin, Depression.

ΠερίληψηSubjectsΒιβλιογραφικά στοιχείαCiteRelated studies

Abstract (original language)

This retrospective study evaluated the association of adjunctive trazodone with sleep architecture, sleep quality, depressive and anxiety symptoms, and circulating 5-HT and BDNF levels in patients with depression. A total of 156 propensity-score-matched patients were included in the final analysis, including 78 who received conventional antidepressant therapy (fluvoxamine monotherapy; control group) and 78 who received combined trazodone and fluvoxamine therapy (observation group). Both treatment regimens were continued for 8 consecutive weeks. Propensity score matching (PSM) was used to balance baseline characteristics between the groups. Sleep architecture, sleep quality, depressive and anxiety symptoms, and circulating 5-HT and BDNF levels were assessed at the prespecified clinical time points. Compared with the control group, the observation group demonstrated significantly reduced awake time, prolonged rapid eye movement (REM) sleep and slow-wave sleep (SWS) duration, improved sleep quality, and lower depression and anxiety scores at week 4 (HAMD: 8.23 ± 1.25 vs. 11.88 ± 2.50; HAMA: 4.35 ± 1.32 vs. 7.89 ± 2.17; both P < 0.001), together with higher circulating 5-hydroxytryptamine (5-HT) and brain-derived neurotrophic factor (BDNF) levels at week 8. Furthermore, the overall clinical response rate was significantly higher in the observation group than in the control group. These findings suggest that adjunctive trazodone was associated with better sleep-related and clinical outcomes, as well as higher circulating 5-HT and BDNF levels, than fluvoxamine monotherapy.

Subjects

MeSH terms (MEDLINE)

TrazodoneBrain-Derived Neurotrophic FactorSerotoninDepressionSleepAffectHumansFemaleMaleRetrospective StudiesFluvoxamineAdultMiddle AgedAntidepressive Agents, Second-Generation

Substances

TrazodoneBrain-Derived Neurotrophic FactorSerotoninFluvoxamineAntidepressive Agents, Second-Generation

Authors and institutions

  • Department of Psychosomatic Medicine, Ward 13, Beijing Hui Long Guan Hospital, Capital Medical University.
  • Department of Psychosomatic Medicine, Ward 13, Beijing Hui Long Guan Hospital, Capital Medical University; bmvnn300q8o@163.com.

Cite

APA

Li, J., Li, L., Li, Q., Zhang, S., & Bian, Y. (2026). Adjunctive Trazodone Effects on Sleep, Mood, and Circulating 5-HT and BDNF in Depression. Journal of Visualized Experiments. https://doi.org/10.3791/73296

Vancouver

Li J, Li L, Li Q, Zhang S, Bian Y. Adjunctive Trazodone Effects on Sleep, Mood, and Circulating 5-HT and BDNF in Depression. Journal of Visualized Experiments. 2026. doi:10.3791/73296

BibTeX
@article{Li2026,
  author = {Li, Juyan and Li, Lingling and Li, Qiuying and Zhang, Suoyuan and Bian, Yun},
  title = {Adjunctive Trazodone Effects on Sleep, Mood, and Circulating 5-HT and BDNF in Depression},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  number = {236},
  doi = {10.3791/73296}
}
Start for free →